share_log

Isracann Biosciences Inc. (OTCMKTS:ISCNF) Short Interest Down 96.5% in January

Financial News Live ·  Jan 28, 2023 10:31

Isracann Biosciences Inc. (OTCMKTS:ISCNF – Get Rating) was the recipient of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 3,300 shares, a drop of 96.5% from the December 31st total of 95,300 shares. Based on an average daily volume of 271,300 shares, the short-interest ratio is presently 0.0 days.

Isracann Biosciences Stock Performance

OTCMKTS:ISCNF remained flat at $0.01 during midday trading on Friday. The company had a trading volume of 159,751 shares, compared to its average volume of 229,803. The business's 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.03. Isracann Biosciences has a 52-week low of $0.01 and a 52-week high of $0.14.

Get Isracann Biosciences alerts:

About Isracann Biosciences

(Get Rating)

Isracann Biosciences Inc, together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc and changed its name to Isracann Biosciences Inc in October 2019.

Further Reading

  • Get a free copy of the StockNews.com research report on Isracann Biosciences (ISCNF)
  • Why Lucid Spiked Nearly 100% In One Day
  • Ride These Railroad Stocks for Growth and Income
  • ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
  • KLA Corporation: Strength In A Troubled Semi-Market
  • PCE Indicates Slowdown In Spending, Economy Weakens

Receive News & Ratings for Isracann Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Isracann Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment